VA-SenaJuly 9, 2020
MedicalPharma-News.jpg

2min44250

Strides Pharma gets USFDA nod to market generic headache drug

MedicalPharma-NewsThe product, which will be marketed by Singapore-based Strides Pharma Inc in the US market, is a generic version of Teva's Fioricet with Codeine capsules, it added.

 Strides Pharma Science on Thursday said its subsidiary has received approval from the US health regulator to market Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate capsules, used in the treatment of headache.

Singapore-based Strides Pharma Global Pte Ltd, a wholly-owned unit of the company, has received approval for the product from the US Food and Drug Administration (USFDA), Strides Pharma Science said in a statement.

The product, which will be marketed by Strides Pharma Inc in the US market, is a generic version of Teva's Fioricet with Codeine capsules, it added.

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate capsules are indicated for relief from headache.

According to IQVIA MAT May 2020 data, the US market for the product is around USD 10 million.

Strides Pharma Science has now 124 cumulative abbreviated new drug application (ANDA) filings with USFDA of which 87 have been approved and 37 are pending for approval.

VA-SenaJuly 2, 2020
COVID-19-Study-01.jpg

5min41410

Weak evidence for accuracy of Covid-19 antibody tests: Study

Serological tests to detect antibodies against Covid-19 could improve diagnosis and may be useful tools for monitoring levels of infection in a population, but it is important to formally evaluate whether there is sufficient evidence that they are accurate, the researchers said.

COVID-19-Study-01 A review of studies has found major weaknesses in the evidence base for diagnostic accuracy of Covid-19 antibody tests, particularly for point-of-care tests performed directly with a patient, outside a laboratory, and does not support their continued use.

Serological tests to detect antibodies against Covid-19 could improve diagnosis and may be useful tools for monitoring levels of infection in a population, but it is important to formally evaluate whether there is sufficient evidence that they are accurate, the researchers said.

The study, published ín The BMJ, set out to determine the diagnostic accuracy of antibody tests for Covid-19.

The researchers, including those from Harvard Medical School in the US and University of British Columbia, Canada, searched medical databases and preprint servers from January 1 to April 30, for studies measuring sensitivity and specificity of a Covid-19 antibody test compared with a control test.

Sensitivity measures the percentage of people who are correctly identified as having a disease, while specificity measures the percentage of people who are correctly identified as not having a disease, they said.

Of 40 eligible studies, most (70 per cent) were from China and the rest were from the UK, US, Denmark, Spain, Sweden, Japan and Germany.

The researchers noted that half of the studies were not peer reviewed and most were found to have a high or unclear risk of bias -- problems in study design that can influence results.

Only four studies included outpatients and only two evaluated tests at the point of care, they said.

When sensitivity results for each study were pooled together, they ranged from 66 per cent to 97.8 per cent depending on the type of test method used, meaning that between 2.2 per cent and 34 per cent of patients with Covid-19 would be missed, according to the researchers.

Pooled specificities ranged from 96.6 to 99.7 per cent, depending on the test method used, meaning that between 3.4 per cent and 0.3 per cent of patients would be wrongly identified as having Covid-19, they said.

The study found that pooled sensitivities were consistently lower for the lateral flow immunoassay (LFIA) test compared with other test methods.

The LFIA test is the potential point-of-care method that is being considered for 'immunity passports.'

The researchers explained that, if an LFIA test is applied to a population with a Covid-19 prevalence of 10 per cent, for every 1,000 people tested, 31 who never had Covid-19 will be incorrectly told they are immune, and 34 people who had the disease will be incorrectly told that they were never infected.

Pooled sensitivities were also lower with commercial test kits (65 per cent) compared with non-commercial kits (88.2 per cent) and in the first and second week after symptom onset compared with after the second week, they said.

The researchers point to some limitations, such as differences in study populations and the potential for missing studies.

However, study strengths include thorough search strategies and assessment of bias, they said.

"These observations indicate important weaknesses in the evidence on Covid-19 serological tests, particularly those being marketed as point-of-care tests," the researchers said.

"While the scientific community should be lauded for the pace at which novel serological tests have been developed, this review underscores the need for high quality clinical studies to evaluate these tools," they added.

VA-SenaJuly 1, 2020
MedicalGuideline-02.jpg

4min40490

COVID-19 Duty: Haryana Deploys Final-Year MBBS Students Amid Rise In Coronavirus Cases

MedicalGuideline-02

The director general of medical education and research in Haryana said in an order that 1,106 final-year MBBS students of 11 government and private medical colleges in the state have been assigned COVID-19 duties and they shall report to civil surgeons of the districts concerned.

Amid rising number of COVID-19 cases, the Haryana Government has said final-year MBBS students studying in government and private medical colleges will be deployed for effective management of the pandemic. The death toll due to COVID-19 in Haryana on Sunday rose to 160 with 11 fresh fatalities, while the infection tally climbed to 10,635 as 412 more people tested positive for the disease, a health department bulletin said.

The director general of medical education and research in Haryana said in an order that 1,106 final-year MBBS students of 11 government and private medical colleges in the state have been assigned COVID-19 duties and they shall report to civil surgeons of the districts concerned.

There has been a surge in the number of COVID-19 positive cases in Haryana. The government is in the process of creating additional healthcare facilities to effectively manage the COVID-19 cases which required additional manpower, the order dated June 19 said.

The government has decided that all final-year MBBS students of all government and private medical colleges in the state shall be deputed with the health department with immediate effect, it said. The directors of medical colleges and civil surgeons shall ensure that the students are provided all necessary training, it added.

According to the order, the students have been asked to report to the civil surgeons concerned by June 22. If needed, the civil surgeons shall also ensure boarding and lodging arrangements for the students, the order stated.

Coronavirus cases in Haryana have risen sharply during the past three weeks, with Gurgaon and Faridabad accounting for majority of the cases as well as fatalities. Of 11 fresh fatalities on Sunday, Gurgaon and Faridabad, among Haryana’s worst-hit districts, accounted for nine fresh fatalities. The death toll in Gurgaon and Faridabad, which fall in the National Capital Region (NCR), has now climbed to 64 and 56, respectively.

The state health department bulletin said with 11 more COVID-19 deaths the total number of fatalities in the state has risen to 160. Of the total fatalities in Haryana, 109 are males and 51 females. With 412 fresh infections, the total number of COVID-19 cases in Haryana rose to 10,635 on Sunday, the bulletin said. Gurgaon alone accounts for 4,427 cases in Haryana, while Faridabad has 2,237 cases.

 


VA-SenaMay 22, 2020
Blackribon-Coronamask-AyushmanHosp-22May20.jpg

5min42080

The ‘black ribbon protest’ has been organised by the Federation of Resident Doctors Association (FORDA) India to express the medical professionals’ disappointment over the revised guidelines for health workers posted in Covid areas, issued by the Union and state health departments.

Blackribon-Coronamask-AyushmanHosp-22May20

 

New Delhi: Doctors deployed in Covid-19 duty in all the Central and state government hospitals on Friday sported black arm bands while at work as a mark of protest.

The ‘black ribbon protest’ has been organised by the Federation of Resident Doctors Association (FORDA) India to express the medical professionals’ disappointment over the revised guidelines for health workers posted in Covid areas, issued by the Union and state health departments.

Deep Chand Bandhu Government Hospital, Sanjay Gandhi Memorial Hospital, Lady Hardinge Medical College (LHMC), Ram Manohar Lohia (RML) Hospital and Lok Nayak Jai Prakash Narayan (LNJP) Hospital in the national capital are a few hospitals where the doctors are currently holding the protest by sporting black arm bands.

The organisers said that if the government does not pay attention to their issues, they will intensify the agitation.

Speaking to IANS, FORDA President Shivaji Dev Barman said, “Today’s ‘black ribbon protest’ at work is for the justified demand for adequate quarantine and testing for all doctors and other healthcare workers who are on Covid-19 duty. Since the incubation period of the virus is 2-14 days and many asymptomatic patients are also testing positive, quarantine post duty is a necessity.

“It is necessary to stop the spread of the virus among the family members, colleagues and in the community. We urge the Union Health Minister to revisit the guidelines and make necessary amendments. We will have to intensify the agitation if the issues are not adequately addressed.”

The government on May 15 issued revised guidelines for the health workers wherein it removed with the mandatory quarantine clause for the health workers post Covid-19 duty, except for those who fit in the ‘high risk exposure’ criteria, thereby revoking the facility for all other doctors and healthcare workers on Covid-19 duty.

Padmini Singla, Delhi government’s Health Secretary, also issued similar guidelines for the hospitals run by the Delhi government.

The doctors claimed that this has put the healthcare workers in a dilemma with remarkable consequences. Parv Mittal, RDA President at Maulana Azad Medical College and Associated Hospitals, told IANS: “The healthcare fraternity is fighting a war on two fronts today. One is the obvious (against Covid-19), the other is the fight for quarantine facilities. The new guidelines have augmented the mental stress of the Covid-19 warriors.”

“The symbolic protest is to register our grievances with the policymakers and urge them to reconsider the quarantine guidelines. Quarantine is a measure to prevent the transmission of the virus to our parents, children and the community at large. Let us not jeopardise the excellent work done by the government for containing the Covid-19 outbreak,” he added.

Saksham Mittal, Joint Secretary of FORDA, and Treasurer of the RDA at RML Hospital, told IANS, “The recent guidelines do not consider the possibility of asymptotic carriers and the accidental exposure of a healthcare worker during the stressful conditions of Covid-19 duties. As the incubation period of the virus is 2-14 days, asking the healthcare workers to resume duty or go home the next day just increases the chance of transmitting the disease to our colleagues and family members.

“We need to safeguard doctors, one of the most important pillars of the frontline health workers to fight this pandemic. We demand 14-day quarantine in a quarantine facility.”

Echoing Mittal’s views, Prateek Goel, General Secretary of the RDA at LNJP Hospital, told IANS, “This is to draw the attention of the Union government and the Delhi government so that they can withdraw the ‘no quarantine’ order. We don’t want your ‘Taali’ and ‘Thaali’. We want to serve the community for which we need proper 14 days of quarantine.”

 

 


VA-SenaMay 22, 2020
Dialog-Corona-AyushmanHosp-22May20.jpg

3min46090

An analysis of the deaths show 64 per cent of the fatalities in males and the remaining 36 per cent in females, the ministry said.

Dialog-Corona-AyushmanHosp-22May20

NEW DELHI: The mortality rate in COVID-19 cases in India is 3.06 per cent as against the global rate of 6.65, the Union health ministry said on Thursday, crediting the efforts towards timely case identification and proper clinical management for this low figure.

An analysis of the deaths show 64 per cent of the fatalities in males and the remaining 36 per cent in females, the ministry said.

Providing an age distribution of the fatalities, the ministry said 0.5 per cent of the deaths are reported in the less than 15 years age group, 2.5 per cent between 15 and 30 years, 11.4 per cent in those aged between 30 and 45, 35.1 per cent between 45-60 years and 50.5 per cent fatalities among people aged above 60 years.

Further, 73 per cent of the deaths had underlying co-morbidities. Elderly people (above 60 years of age) and people having co-morbidities are identified as high risk groups for COVID-19.

 

“The case mortality rate in India is 3.06 per cent, which is much lesser in comparison to the global case mortality rate of 6.65 pc. This brings into focus our efforts towards timely case identification and proper clinical management of the cases,” the ministry said in its statement.

The death toll due to COVID-19 rose to 3,435 and the number of cases climbed to 1,12,359 in the country in a 24-hour span till Thursday 8 AM, registering an increase of 132 deaths and 5,609 cases.

A total of 45,299 patients have recovered so far and 3,002 people have been cured in the last 24 hours, the ministry said.

“The recovery rate is improving continuously and is 40.32 per cent currently,” it said.

India currently has 63,624 active cases. These are all under active medical supervision. Of the active cases, around 2.94 per cent of the cases are in ICU, the statement said.

It is advised that community awareness on COVID-19 appropriate behaviour is an important intervention for prevention for spread of this disease, the ministry said as it stressed on the need to focus on personal hygiene, hand hygiene, and respiratory etiquettes and environmental sanitation.

Face covers and masks should be used in public places and physical distancing should be followed. Large gatherings should be avoided. Individuals in high risk groups should stay at home except for essential and health purposes, it said.


VA-SenaMay 22, 2020
CAGR-AyushmannHosp-22May20.jpg

4min41910

According to Frost & Sullivan, The telehealth market in the United States (US) is estimated to display staggering seven-fold growth by 2025, resulting in a five-year compound annual growth rate (CAGR) of 38.2%. In 2020, the telehealth market is likely to experience a tsunami of growth, resulting in a year-over-year increase of 64.3%.

 

CAGR-AyushmannHosp-22May20

 

California: The demand for telehealth technology is expected to rise dramatically as the COVID-19 pandemic has continued to disrupt the practice of medicine and the delivery of healthcare worldwide.

“The critical need for social distancing among physicians and patients will drive unprecedented demand for telehealth, which involves the use of communication systems and networks to enable either a synchronous or asynchronous session between the patient and provider,” said Victor Camlek, Healthcare Principal Analyst at Frost & Sullivan.

According to Frost & Sullivan, The telehealth market in the United States (US) is estimated to display staggering seven-fold growth by 2025, resulting in a five-year compound annual growth rate (CAGR) of 38.2%. In 2020, the telehealth market is likely to experience a tsunami of growth, resulting in a year-over year increase of 64.3%.

“However, all stakeholders need to remember that many people use the terms ‘telehealth’ or ‘telemedicine’ without understanding the ecosystem that is involved. This study will clarify the many components that are needed in order to implement telehealth. Across the market segments, virtual visits and remote patient monitoring (RPM) will propel the overall market of telehealth, followed by mHealth and personal emergency response systems (PERS).”

 

The opportunity for telehealth products and services to become a standard of care is growing. The challenge facing these technology and healthcare providers will focus on their ability to scale-up to this unprecedented demand. Growth in the telehealth space will be sustained beyond the COVID-19 pandemic for the vendors who can deliver:

The opportunity for telehealth products and services to become a standard of care is growing. The challenge facing these technology and healthcare providers will focus on their ability to scale-up to this unprecedented demand. Growth in the telehealth space will be sustained beyond the COVID-19 pandemic for the vendors who can deliver:

The opportunity for telehealth products and services to become a standard of care is growing. The challenge facing these technology and healthcare providers will focus on their ability to scale-up to this unprecedented demand. Growth in the telehealth space will be sustained beyond the COVID-19 pandemic for the vendors who can deliver:

  • User-friendly sensors and remote diagnostic equipment that yield a high rate of successful patient outcomes following the telehealth experience.
  • Practical applications of artificial intelligence (AI), Interactive Virtual Assistants (IVAs), and robotics that expand the telehealth deployment model.
  • Deployment of big data analytics that can help researchers learn more about the way COVID-19 progresses among diverse patient populations.
  • Adherence to cybersecurity and privacy regulations that avoid data breaches following the use of telehealth services.
  • Measurable data that confirms the value of telehealth and influences regulatory agencies at the federal and state levels to extend all emergency waivers beyond the pandemic.

VA-SenaMay 22, 2020
MedicalGuideline-HarshWHOchr-22May20.jpg

2min44290

WHO is already providing leadership to the entire world in the sphere of public health, engaging with partners for joint actions, shaping the research agenda and stimulating the dissemination of valuable knowledge. The need is to catalyze further change, he said

MedicalGuideline-HarshWHOchr-22May20

New Delhi: Dr Harsh Vardhan, Minister of Health and Family Welfare, India, was today elected the Chair of World Health Organization’s Executive Board.

“I feel deeply honored to have the trust and faith of all of you. India, and my countrymen, too, feel privileged that this honor has been bestowed upon us. I will work to realize the collective vision of our organization, to build the collective capacity of all our Member nations and to build a heroic collective leadership,” Dr Harsh Vardhan said addressing the 147th WHO Executive Board session as its Chair. The session was held virtually.

WHO is already providing leadership to the entire world in the sphere of public health, engaging with partners for joint actions, shaping the research agenda and stimulating the dissemination of valuable knowledge. The need is to catalyze further change, he said.

Health is central to enhancing human capabilities. Protecting health of those without wealth should be the core philosophy of our close alliance at the WHO, Dr Harsh Vardhan said.


VA-SenaMay 20, 2020

1min36820

IGAU Sarkari Jobs Recruitment 2020 – Laboratory Technician Jobs in Raipur

IGAU Recruitment 2020-Apply Online in 36 Lab Technician, Assistant ...

IGAU Sarkari Naukri Latest Job Updates 2020: 15/05/2020 को, IGAU ने प्रयोगशाला के तकनीशियन की स्थिति के लिए, B.Sc, B.Tech/B.E उत्तीर्ण उम्मीदवारों के लिए नौकरी अधिसूचना की घोषणा की। पहला पदनाम: प्रयोगशाला के तकनीशियन शैक्षिक योग्यता: B.Sc, B.Tech/B.E रिक्तियां: 12 पदनाम वेतन: रुपये. 28,700 – 91,300/-Per Month अनुभव: फ्रेशर नौकरी करने का स्थान: रायपुर आवेदन करने की अंतिम तिथि: 30/06/2020

 


VA-SenaMay 20, 2020
AIIMSBHopal-20May20.jpg

3min49570

 

 

AIIMSBHopal-20May20

 

AIIMS Bhopal Senior Resident Jobs 2020 Notification is released. And this commercial is for 78 Senior Resident Vacancies. Interested Candidates after checking all the details can go beforehand and apply for it before the remaining date. twelfth February 2020 is the very last date to use. Here is a superb chance for the people, who are looking for Government Jobs inside the Madhya Pradesh State. Check out the total records given in the Official AIIMS Bhopal Senior Resident Jobs 2020 Notification.

 

And then proceed to apply for the AIIMS Bhopal Jobs 2020 earlier than the deadline. This is a pleasant trap for the people, who’re searching out Government Jobs inside the Medical Field. Also, the aspirants should remember the reality that having the Mere qualifications will not make the contenders eligible, to apply for the AIIMS Bhopal Senior Resident Vacancy 2020. AIIMS Bhopal Officials are very specific that they are seeking out the contenders, who are having all of the Qualifications correctly.

AIIMS Bhopal Senior Resident Jobs 2020 – 78 Posts, Date, Apply Online

AIIMS Bhopal Senior Resident Jobs 2020 Notification

Name Of The Organization

All India Institute of Medical Sciences, Bhopal (AIIMS)

Name Of The Posts

Senior Resident

 

Number Of Posts

78 Posts

 

Starting Date

17th January 2020

 

Ending Date

12th February 2020

 

Category

Government Jobs in India

 

Selection Process

Interview

 

Job Location

Madhya Pradesh

 

Official Site

aiimsbhopal.edu.in

 

MPPSC Recruitment

MP Employment News

 

Senior Resident Jobs

MD Govt Jobs

 

Post-Wise Information

 

Name of the Department

No of Posts

 

Anatomy

02

 

Microbiology

02

 

Community & Family Medicine

03

 

General Medicine

13

 

Psychiatry

03

 

Pediatrics

05

 

General Surgery

14

 

Orthopedics

04

 

Obstetrics & Gynecology

04

 

Radiodiagnosis

06

 

Anesthesiology

04

 

ENT

02

 

Physical Medicine & Rehabilitation

01

 

Endocrinology & Metabolism

02

 

Pulmonary Medicine

02

 

Nuclear Medicine

02

 

Trauma & Emergency Medicine

05

 

Transfusion Medicine & Blood Bank 03

Pharmacology 01

Total 78

 

Educational Qualification

 

Well, to apply for the AIIMS Bhopal Senior Resident Jobs 2020, an individual must have completed their Ph.D. from any Recognized Institute or University in India, as the Educational Qualification.

Age Limit

 

Well, the candidates with Maximum age of 37 Years. For age relaxation, check the AIIMS Bhopal Senior Resident Jobs 2020 Notification.


VA-SenaMay 19, 2020
WHO-Prepare-newcases.jpg

7min44630

WHO: People living longer and healthier lives but COVID-19 threatens to throw progress off track

 

WHO-Prepare-newcases

 

All over the world, the COVID-19 pandemic is causing significant loss of life, disrupting livelihoods, and threatening the recent advances in health and progress towards global development goals highlighted in the 2020 World Health Statistics published by the World Health Organization (WHO) today.

“The good news is that people around the world are living longer and healthier lives. The bad news is the rate of progress is too slow to meet the Sustainable Development Goals and will be further thrown off track by COVID-19,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.

“The pandemic highlights the urgent need for all countries to invest in strong health systems and primary health care, as the best defense against outbreaks like COVID-19, and against the many other health threats that people around the world face every day. Health systems and health security are two sides of the same coin.”

WHO’s World Health Statistics — an annual check-up on the world’s health — reports progress against a series of key health and health service indicators, revealing some important lessons in terms of progress made towards the Sustainable Development Goals and gaps to fill.

Life expectancy and healthy life expectancy have increased, but unequally.

The biggest gains were reported in low-income countries, which saw life expectancy rise 21% or 11 years between 2000 and 2016 (compared with an increase of 4% or 3 years in higher income countries).

One driver of progress in lower-income countries was improved access to services to prevent and treat HIV, malaria and tuberculosis, as well as a

number of neglected tropical diseases such as guinea worm. Another was better maternal and child healthcare, which led to a halving of child mortality between 2000 and 2018.

But in a number of areas, progress has been stalling. Immunization coverage has barely increased in recent years, and there are fears that malaria gains may be reversed. And there is an overall shortage of services within and outside the health system to prevent and treat noncommunicable diseases (NCDs) such as cancer, diabetes, heart and lung disease, and stroke. In 2016, 71 per cent of all deaths worldwide were attributable to NCDs, with the majority of the 15 million premature deaths (85%) occurring in low and middle-income countries.

This uneven progress broadly mirrors inequalities in access to quality health services. Only between one third and one half the world’s population was able to obtain essential health services in 2017. Service coverage in low- and middle-income countries remains well below coverage in wealthier ones; as do health workforce densities. In more than 40% of all countries, there are fewer than 10 medical doctors per 10 000 people. Over 55% of countries have fewer than 40 nursing and midwifery personnel per 10 000 people.

The inability to pay for healthcare is another major challenge for many. On current trends, WHO estimates that this year, 2020, approximately 1 billion people (almost 13 per cent of the global population) will be spending at least 10% of their household budgets on health care. The majority of these people live in lower middle-income countries.

“The COVID-19 pandemic highlights the need to protect people from health emergencies, as well as to promote universal health coverage and healthier populations to keep people from needing health services through multisecotral interventions like improving basic hygiene and sanitation,” said Dr Samira Asma, Assistant Director General at WHO.

In 2017, more than half (55%) of the global population was estimated to lack access to safely-managed sanitation services, and more than one quarter (29%) lacked safely-managed drinking water. In the same year, two in five households globally (40%) lacked basic handwashing facilities with soap and water in their home.

The World Health Statistics also highlight the need for stronger data and health information systems. Uneven capacities to collect and use accurate, timely, and comparable health statistics, undermining countries’ ability to understand population health trends, develop appropriate policies, allocate resources and prioritize interventions.

For almost a fifth of countries, over half of the key indicators have no recent primary or direct underlying data, another major challenge in enabling countries to prepare for, prevent and respond to health emergencies such as the ongoing COVID-19 pandemic. WHO is therefore supporting countries in strengthening surveillance and data and health information systems so they can measure their status and manage improvements.

“The message from this report is clear: as the world battles the most serious pandemic in 100 years, just a decade away from the SDG deadline, we must act together to strengthen primary health care and focus on the most vulnerable among us in order to eliminate the gross inequalities that dictate who lives a long, healthy life and who doesn’t,” added Asma. “We will only succeed in doing this by helping countries to improve their data and health information systems.”

Note for editors

The World Health Statistics have been compiled primarily from publications and databases produced and maintained by WHO or by United Nations (UN) groups of which WHO is a member, such as the UN Interagency Group for Child Mortality Estimation. In addition, some statistics have been derived from data produced and maintained by other international organizations, such as the UN Department of Economic and Social Affairs and its Population Division. The Global Health Observatory database contains additional details about the health-related SDG indicators, as well as interactive visualizations.